Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ENROFLOXACIN
Bayer Limited
QJ01MA90
ENROFLOXACIN
50 Mg/Ml
Solution for Injection
POM
Bovine, Canine, Caprine, Feline, Ovine, Porcine
Enrofloxacin
Antibacterial
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Baytril 50 mg/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution contains: ACTIVE SUBSTANCE: Enrofloxacin: 50 mg EXCIPIENT(S): n-Butyl alcohol: 30 mg. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear light yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (calves), sheep, goats, pigs, dogs and cats. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _8_ _/_ _0_ _4_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _6_ _6_ _2_ _4_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Calves Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of_ Pasteurella multocida,_ _Mannheimia haemolytica_ and_ Mycoplasma_ spp. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of_ Escherichia coli._ Treatment of septicaemia caused by enrofloxacin susceptible strains of_ Escherichia coli._ Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of_ Mycoplasma bovis._ Sheep Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of_ Escherichia coli._ Treatment of septicaemia caused by enrofloxacin susceptible strains of_ Escherichia coli._ Treatment of mastitis caused by enrofloxacin susceptible strains of_ Staphylo Read the complete document